HUM

$171.38+1.39 (+0.82%)

Market OpenAs of Mar 17, 7:10 PM UTC

Humana Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$171.38
Potential Upside
11.4%
Whystock Fair Value$190.97
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealthcare Plans

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, inclu...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$20.67B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
17.42
Beta
Defensive asset. Lower volatility than the S&P 500.
0.41
Div Yield
Strong income play. Yield provides a meaningful total return floor.
208.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
7.04%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.53

Recent News

Zacks
Mar 17, 2026

UNH Expands Doulas: Better Outcomes or Margin Play Ahead?

UnitedHealth Group rolls out nationwide doula coverage, targeting better maternal outcomes and lower costs through preventive, value-based care.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 17, 2026

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 16, 2026

Here's Why Genpact Stock Is a Compelling Pick for You Right Now

Genpact gains momentum as BPO, AI and digital transformation demand drive growth, while rising earnings estimates and steady revenue expansion signal strength.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 14, 2026

Are Humana’s (HUM) Executive Severance Defenses Undercutting Its Patient-Centric Investment Story?

Recently, Humana Inc. received a shareholder proposal from activist John Chevedden seeking shareholder approval for executive severance packages above 2.99 times salary and target bonus, which the board has urged investors to vote against at the April 16, 2026 annual meeting. At the same time, Humana has been expanding member-focused benefits, such as broader access to continuous glucose monitors for Medicare Advantage enrollees, underscoring a growing tension between executive pay practices...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 13, 2026

Why Is Humana (HUM) Down 8.5% Since Last Earnings Report?

Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.